Eliminating Akt1 from human IECs in vitro resulted in greater expression of occludin and claudin 4, and mice lacking GC-C exhibited lower levels of occludin and claudin-4, intestinal hyperpermeability and susceptibility to DSS-induced colitis [172]. The gene discussed is CLDN4; the disease is colitis.